Hims Hair Loss Review 2026: Does This Telehealth Treatment Actually Regrow Hair?

Hair loss is one of the most emotionally charged health issues a man can face, and the market for solutions is flooded with products that promise everything and deliver nothing. Hims is different — not because it has invented something new, but because it has made genuinely proven treatments more accessible than ever before. After nine months of real-world testing, we have a clear picture of what Hims actually delivers, who it works for, and where it falls short.

Background

Hims launched in 2017 as a telehealth platform targeting men's health issues — primarily hair loss, erectile dysfunction, and skincare. The company went public via SPAC in 2021 and has since expanded significantly. Its hair loss offering is built around two FDA-approved treatments: minoxidil (the active ingredient in Rogaine) and finasteride (the active ingredient in Propecia). What Hims does differently is combine telehealth convenience with prescription access, allowing men to get finasteride — which requires a prescription — without an in-person doctor visit.

What Is It?

Hims offers several hair loss products: topical minoxidil 5% solution, oral finasteride 1mg tablets, a topical finasteride-minoxidil spray (combination formula), and an advanced 4-in-1 spray containing finasteride 0.3%, minoxidil 7%, ketoconazole 2.2%, and biotin 0.2%. The process begins with an online intake form and photo submission, which a licensed provider reviews before issuing a prescription if appropriate. Products are shipped directly to your door.

The Good Stuff

The core treatments work. Minoxidil and finasteride are among the most well-studied hair loss treatments in existence, with decades of clinical data supporting their effectiveness. In our 9-month test, the tester using the topical finasteride-minoxidil combination spray reported visible improvement in shedding by month two, measurable thickness improvement by month four, and a 4/5 satisfaction rating at the end of the test period. The telehealth model is genuinely convenient — no waiting rooms, no awkward conversations, and prescriptions delivered to your door. Pricing is competitive at approximately $50 per month for the combination spray.

The Problems

The initial shed — a temporary increase in hair loss during the first 4–8 weeks — is real and can be alarming if you are not prepared for it. Hims does not do enough to educate users about this phase upfront. Finasteride carries real potential side effects, including sexual dysfunction in a small percentage of users, and the telehealth model means you may not have the same depth of consultation as you would with an in-person dermatologist. Results require months of consistent use, and stopping treatment reverses any gains within 3–4 months — meaning this is a lifelong commitment, not a cure.

Price Breakdown

Hims pricing varies by product. Topical minoxidil starts at around $20/month. Oral finasteride is approximately $25/month. The combination topical spray runs about $50/month. A three-month supply of the combination formula costs approximately $150. Over 10 years of consistent use, that totals roughly $6,000 — which the company itself notes is significantly less than the $15,000–$25,000 cost of a hair transplant.

Hims is not a miracle product, but it is a legitimate, evidence-based solution for men with early to moderate male pattern baldness. The telehealth model makes proven treatments more accessible, the pricing is reasonable, and the results — when used consistently — are real. The key caveats are that it requires a long-term commitment, the initial shed can be discouraging, and it is not appropriate for everyone. If you are noticing early signs of hair thinning, Hims is worth a serious look.

Final Score: 4/5 — Proven ingredients, convenient delivery, real results — but requires patience and lifelong commitment.